-
-
Panic symptoms in transient loss of consciousness: Frequency and diagnostic value in psychogenic nonepileptic seizures, epilepsy and syncope
-
Effect of agomelatine 25-50mg on functional outcomes in patients with major depressive disorder
-
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial
-
The role of adult attachment orientation and coping in psychological adjustment to living with skin conditions
-
Physical comorbidity and consequences for mortality and treatment
Conference Abstract
-
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
Randomised Controlled Trial
-
Efficacy of agomelatine in more anxious elderly depressed patients. A randomized, double-blind study vs placebo.
-
Efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression: a randomised controlled trial
-
Comorbid medical illness in bipolar disorder.
Letter
-
Sustained efficacy and safety of agomelatine versus placebo over 24 weeks in elderly out-patients suffering from major depressive disorder
-
Entrapment and Defeat Perceptions in Depressive Symptomatology: Through an Evolutionary Approach.